Growth Metrics

Artivion (AORT) Divestments (2016 - 2017)

Artivion posted quarterly Divestments of $740000.0 for Q1 2017, down 96.26% year-on-year from $19.8 million in Q1 2016, and down 96.26% on a QoQ basis from $19.8 million in Q1 2016.

Artivion (AORT) has 2 years of Divestments data on file, last reported at $740000.0 in Q1 2017.

  • For the quarter ending Q1 2017, Divestments fell 96.26% year-over-year to $740000.0; the trailing twelve-month figure through Dec 2017 stood at $740000.0 (down 96.26% YoY), and the FY2017 full-year result was $740000.0, down 96.26% from the prior year.
  • Divestments for Q1 2017 stood at $740000.0, down from $19.8 million in the prior quarter.
  • Across five years, Divestments topped out at $19.8 million in Q1 2016 and bottomed at $740000.0 in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2017 740,000.00
Mar 31, 2016 19.80 Mn